Citations

Showing 10 of 108104 citations.

Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs. routine surveillance in lung cancer patients: Final results.
Denis, Fabrice , Basch, Ethan , Lethrosne, Claire, Pourel, N. , Molinier, Olivier , Pointreau, Y. , Dômont, Julien , Bourgeois, Hugues , Senellart, Hélène, Urban, T. , Septans, Anne-Lise , Balavoine, Magal, Solal‐Céligny, Philippe , Basch, Ethan , Bennouna, Jaafar , Balavoine, Magali , Dueck, Amylou C. , Letellier, Christophe

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 6500-6500

10.1200/jco.2018.36.15_suppl.6500 Get It

Prediction of post-operative residual disease in advanced-stage ovarian cancer (AOC) using whole transcriptome expression: An exploratory analysis of the AGO-OVAR 11 (ICON7) trial.
Kommoss, Stefan , Winterhoff, Boris , Aliferis, Constantin , Burges, Alexander , Canzler, Ulrich , Wang, Jinhua , Belau, Antje , Hanker, Lars , Ma, Sisi , Hilpert, Felix , Tourani, Roshan , Kimmig, Rainer , Kurzeder, Christian , Schmalfeldt, Barbara , Dowdy, Sean C. , Pfisterer, Jacobus , Heitz, Florian , Wang, Chen , Ma, Sisi , Sehouli, Jalid , Bois, Andreas du

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5550-5550

10.1200/jco.2018.36.15_suppl.5550 Get It

Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab.
Kommoss, Stefan , Winterhoff, Boris , Wang, Chen , Aliferis, Constantin , Kimmig, Rainer , Wang, Jinhua , Ma, Sisi , Gregorio, Nikolaus de , Mahner, Sven� , Tourani, Roshan , Park‐Simon, Tjoung‐Won , Baumann, Klaus , Taran, Florin‐Andrei , Kommoss, Friedrich, Schroeder, W., Dowdy, Sean C. , Pfisterer, Jacobus , Heitz, Florian , Sehouli, Jalid , Ma, Sisi , Bois, Andreas du

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5520-5520

10.1200/jco.2018.36.15_suppl.5520 Get It

QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
Miller, David S. , Cloven, Noelle, Hendrickson, Andrea E. Wahner , DiSilvestro, Paul , Cristea, Mihaela , Berek, Jonathan S. , Chan, John K. , Clark, Romnee, Matulonis, Ursula A. , Monk, Bradley J. , Miller, David S , Moore, Kathleen N. , Secord, Angeles Alvarez , Geller, Melissa Ann , Fleming, Gini F. , Azodi, Masoud , Oza, Amit M. , Li, Yong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5514-5514

10.1200/jco.2018.36.15_suppl.5514 Get It

Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression.
Armenia, Joshua , Yoshikawa, Yuki , Gerke, Travis , Komura, Kazumasa , Lee, Gwo‐Shu Mary , Mucci, Lorelei A. , Mazzu, Ying Zhang , Chakraborty, Goutam , Atiq, Mohammad Omar , Stopsack, Konrad H. , Kantoff, Philip W.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5044-5044

10.1200/jco.2018.36.15_suppl.5044 Get It

Testicular germ cell tumors with malignant somatic component: A single-center experience.
Scheckel, Caleb , Butterfield, Richard , Kosiorek, Heidi , Ho, Thai H. , Hilal, Talal

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16544-e16544

10.1200/jco.2018.36.15_suppl.e16544 Get It

A transcriptome analysis of castration resistant prostate cancer metastases in a prospective cohort study reveals high expression of AKT pathway genes predictive of long term response to abiraterone acetate/prednisone.
Tan, Winston , Jiménez, Rafael E. , Weinshilboum, Richard M. , Sicotte, Hugues , Kohli, Manish , Dehm, Scott M. , Bhargava, Vipul , Gormley, Michael , Sinnwell, Jason P. , Hillman, David W. , Li, Ying , Weinshilboum, Richard M. , Kalari, Krishna R. , Wang, Liguo

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5038-5038

10.1200/jco.2018.36.15_suppl.5038 Get It

A meta-analysis of randomized controlled trials for efficacy and safety of vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) adjuvant therapy in high-risk renal cell cancer (RCC).
Malik, Saad Ullah , Sipra, Qurat Ul Ain Riaz , Faridi, Warda, Gondal, Farva R. , Riaz, Irbaz Bin , Husnain, Muhammad , Xie, Hao , Yadav, Siddhartha , Kohli, Manish

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4567-4567

10.1200/jco.2018.36.15_suppl.4567 Get It

Association between changing body composition after diagnosis and survival of patients with advanced pancreatic cancer.
Rosenthal, Michael H. , Babić, Ana , Morales‐Oyarvide, Vicente, Welch, Marisa W., Zellers, Caitlin L., Denai, Laura, Clish, Clary B. , Petersen, Gloria M. , Wolpin, Brian M. , Clish, Clary , Bamlet, William R. , Takahashi, Naoki, Khalaf, Natalia , Brais, Lauren K , Vander Heiden, Matthew G

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16247-e16247

10.1200/jco.2018.36.15_suppl.e16247 Get It